AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glikla-M Tablet

Prescription Icon
Prescription Required

Marketer

Dr. Patro's Research Laboratories (OPC) Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glikla-M Tablet

DiaBetaDuo tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This dual-action formulation helps manage blood glucose levels. DiaBetaDuo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, increasing the risk of complications including kidney disease, vision loss, neuropathy, and limb amputation. DiaBetaDuo is one component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and nausea. Always carry a fast-acting sugar source to counteract hypoglycemia and maintain regular mealtimes. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects are altered taste, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiaBetaDuo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Glikla-M Tablet

Adult-onset diabetes

Major Benefits of Glikla-M Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume Glikla-M Tablet with a meal.

Common Side effects of Glikla-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glikla-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Glikla-M Tablet with a meal.

How Glikla-M Tablet works:

Glikla-M tablets contain a dual-action formulation of gliclazide and metformin, both used in the management of diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Glikla-M Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glikla-M Tablet during pregnancy poses a confirmed risk to the fetus, making it inadvisable. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glikla-M Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glikla-M Tablets, potentially requiring dosage modification. Severe kidney disease contraindicates Glikla-M Tablet use. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glikla-M Tablet cautiously, potentially requiring dosage modification. Consult a physician. Individuals with mild to moderate liver disease should typically begin with a low Glikla-M Tablet dosage; its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glikla-M Tablet :

Should you forget a Glikla-M Tablet dose, administer it promptly. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glikla-M Tablet

LabelValue
Developing Good Habits No.
Type of Therapy Diabetes Management

FAQs on Glikla-M Tablet

Glikla-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 diabetes.
Glikla-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glikla-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glikla-M Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is less likely in patients without kidney disease, who are not elderly, and who avoid excessive alcohol consumption. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glikla-M immediately and seek medical attention.
Prolonged Glikla-M Tablet use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Glikla-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Glikla-M tablets is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Glikla-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glikla-M is not suitable for type 1 diabetes.
Glikla-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Glikla-M Tablets can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medications are taken concurrently. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glikla-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glikla-M and seek immediate medical attention.
Prolonged Glikla-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glikla-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glikla-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glikla-M Tablet
63
MRP 77
18% off